These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7774760)

  • 1. Zolpidem in insomnia: a 3-year post-marketing surveillance study in Switzerland.
    Ganzoni E; Santoni JP; Chevillard V; Sébille M; Mathy B
    J Int Med Res; 1995; 23(1):61-73. PubMed ID: 7774760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and tolerance of zolpidem in the treatment of disturbed sleep: a post-marketing surveillance of 16944 cases.
    Hajak G; Bandelow B
    Int Clin Psychopharmacol; 1998 Jul; 13(4):157-67. PubMed ID: 9727726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Safety profile of zolpidem: two studies of 3805 patients by Swiss practitioners].
    Ganzoni E; Gugger M
    Praxis (Bern 1994); 1999 Jun; 88(25-26):1120-7. PubMed ID: 10429550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.
    Roger M; Attali P; Coquelin JP
    Clin Ther; 1993; 15(1):127-36. PubMed ID: 8458042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and efficacy of zolpidem in insomniac patients: a long-term open study in general practice.
    Maarek L; Cramer P; Attali P; Coquelin JP; Morselli PL
    J Int Med Res; 1992 Apr; 20(2):162-70. PubMed ID: 1521672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zolpidem for insomnia.
    Greenblatt DJ; Roth T
    Expert Opin Pharmacother; 2012 Apr; 13(6):879-93. PubMed ID: 22424586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and tolerability of zolpidem--an update.
    Darcourt G; Pringuey D; Sallière D; Lavoisy J
    J Psychopharmacol; 1999; 13(1):81-93. PubMed ID: 10221362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, comparative study of zolpidem and placebo in the treatment of insomnia in elderly psychiatric in-patients.
    Shaw SH; Curson H; Coquelin JP
    J Int Med Res; 1992 Apr; 20(2):150-61. PubMed ID: 1521671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous adverse event reports associated with zolpidem in Australia 2001-2008.
    Ben-Hamou M; Marshall NS; Grunstein RR; Saini B; Fois RA
    J Sleep Res; 2011 Dec; 20(4):559-68. PubMed ID: 21481053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia.
    Hoehns JD; Perry PJ
    Clin Pharm; 1993 Nov; 12(11):814-28. PubMed ID: 8275648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of the therapeutic management of insomnia with zolpidem.
    Lee YJ
    CNS Drugs; 2004; 18 Suppl 1():17-23; discussion 41, 43-5. PubMed ID: 15291010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB; Roth T; Vogel GW; Walsh JK
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment of insomnia with zolpidem: a multicentre general practitioner study of 107 patients.
    Schlich D; L'Heritier C; Coquelin JP; Attali P; Kryrein HJ
    J Int Med Res; 1991; 19(3):271-9. PubMed ID: 1670039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Abrupt shift to zolpidem, a new imidazopyridine hypnotic, in insomniac patients previously treated with benzodiazepine hypnotics].
    Ciapparelli A; Colombo C; Cuccato G; Levi-Minzi A; Lorizio A; Maggioni M; Siciliano G; Silvestri R; Biondi F; Casadei GL
    Minerva Psichiatr; 1993 Mar; 34(1):29-38. PubMed ID: 8098502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.
    Monti JM; Attali P; Monti D; Zipfel A; de la Giclais B; Morselli PL
    Pharmacopsychiatry; 1994 Jul; 27(4):166-75. PubMed ID: 7972349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zolpidem--a hypnotic with a difference?
    Drug Ther Bull; 1995 May; 33(5):37-9. PubMed ID: 7587994
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypnotics in insomnia: the experience of zolpidem.
    MacFarlane J; Morin CM; Montplaisir J
    Clin Ther; 2014 Nov; 36(11):1676-701. PubMed ID: 25455931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of zolpidem on sleep architecture and its next-morning residual effect in insomniac patients: a randomized crossover comparative study with brotizolam.
    Uchimura N; Nakajima T; Hayash K; Nose I; Hashizume Y; Ohyama T; Habukawa M; Kotorii N; Kuwahara H; Maeda H
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):22-9. PubMed ID: 16048734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmarketing surveillance of zopiclone in insomnia: analysis of 20,513 cases.
    Allain H; Delahaye C; Le Coz F; Blin P; Decombe R; Martinet JP
    Sleep; 1991 Oct; 14(5):408-13. PubMed ID: 1759093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double blind comparison of zolpidem 20 mg versus flunitrazepam 2 mg in insomniac in-patients.
    Frattola L; Maggioni M; Cesana B; Priore P
    Drugs Exp Clin Res; 1990; 16(7):371-6. PubMed ID: 2092963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.